In the light of scarce resources to be allocated for cancer care and a steady stream of costly innovations in all modalities applied to treat cancer, particle therapy needs to demonstrate its cost-utility balance to allow its positioning in the context of competing modalities. In the continuous evolving particle therapy landscape, the timely availability of appropriate economic data is crucial.
from Imaging via alkiviadis.1961 on Inoreader http://bit.ly/2GUQg5a
Πέμπτη 29 Μαρτίου 2018
Economic data for particle therapy: Dealing with different needs in a heterogeneous landscape
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
New analysis shows that some of these amazing flying beasts were far more formidable than we'd ever thought before... -- Read more on...
-
Do you speak NHS?Oh, yes: you don’t get far in the health service without being able to generate a seamless flow of the right words, if only...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oDLxf6 via IFTTT
-
The government has announced its intention to make sex and relationships education (SRE) statutory in all secondary schools, and to make rel...
-
Abstract Purpose The aim of this study is to evaluate the feasibility of a telehealthcare application for operable lung cancer (OLC) patie...
-
Bristol-Myers Squibb Co Cancer Drug Cost Comes Under Fire In U.K. StockNews.com (blog) NICE noted the evidence that nivolumab can ext...
-
Abstract Background Medical therapy efficacy remains controversial in stricturing Crohn's disease. Cross-sectional imaging, especial...
-
Abstract The applicability of comprehensive two-dimensional gas chromatography (GC×GC) using a single-stage thermal modulator was explored...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o3hqws via IFTTT
-
Abstract Patients with sulfite oxidase (SO) deficiency present severe brain abnormalities, whose pathophysiology is not yet elucidated. We...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου